Soligenix Inc - Company Profile

Powered by

All the data and insights you need on Soligenix Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Soligenix Inc Strategy Report

  • Understand Soligenix Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Soligenix Inc: Overview

Select Item

Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development and commercialization of products for the treatment of rare diseases and unmet medical needs. It develops specialized biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymphoma, pediatric Crohn's disease, oral mucositis, mild to moderate psoriasis, and acute radiation enteritis. It develops proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the treatment of gastrointestinal disorders that are characterized by high inflammation. The company has active development programs for RiVax, a ricin toxin vaccine; and SGX943 for infectious disease. These vaccine programs are supported by ThermoVax, a heat stabilization technology. Soligenix is headquartered in Princeton, New Jersey, the US.

 Gain a 360-degree view of Soligenix Inc and make more informed decisions for your business Gain a 360-degree view of Soligenix Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address Suite C-10, 29 Emmons Drive, Princeton, New Jersey, 08540
Website www.soligenix.com
Telephone 1 609 5388200
No of Employees 13
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange SNGX (NASD)
Revenue (2022) $839,400 -11.5% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 55.5% (2022 vs 2021)
Market Cap* $5.0M
Net Profit Margin (2022) XYZ 49.7% (2022 vs 2021)
* As of and is in US$
View Soligenix Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Soligenix Inc premium industry data and analytics

40+

Catalyst Calendar

Proactively evaluate Soligenix Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

30+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Soligenix Inc’s relevant decision makers and contact details.

20+

Clinical Trials

Determine Soligenix Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Soligenix Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

8

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
Pipeline:- -
Specialized BioTherapeutics: ThermoVax
HyBryte- Cutaneous T-Cell Lymphoma RiVax
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Soligenix Inc portfolio and identify potential areas for collaboration Understand Soligenix Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In May, the company entered into an option agreement with Silk Road Therapeutics to acquire a novel topical formulation of Pentoxifylline (PTX).
2022 Contracts/Agreements In July, the company entered into partnership agreement with SERB Pharmaceuticals to supply ricin antigen.
2021 Patent Grant In May, Japan Patent Office granted patent titiled “Systems and Methods for Producing Synthetic Hypericin”
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Soligenix Inc Novartis AG Precigen Inc Cellerant Therapeutics Inc Exponential Biotherapies Inc
Headquarters United States of America Switzerland United States of America United States of America Netherlands
City Princeton Basel Germantown San Carlos Den Haag
State/Province New Jersey - Maryland California -
No. of Employees 13 76,057 202 - -
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Christopher J. Schaber, Ph.D. Chief Executive Officer; President; Chairman Executive Board 2009 56
Jonathan Guarino Secretary; Chief Financial Officer; Senior Vice President Senior Management 2019 50
Richard C. Straube, M.D. Senior Vice President; Chief Medical Officer Senior Management 2014 71
Oreola Donini, Ph.D. Chief Scientific Officer; Senior Vice President Senior Management 2014 51
Adam T. Rumage Vice President - Project Management & Regulatory Affairs Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Soligenix Inc key executives to enhance your sales strategy Gain insight into Soligenix Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward